Trial site
Tribe Clinical Research LLC
- 15running trials
- 14closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Obesity15 trials
- Type 2 diabetes10 trials
- Migraine4 trials
- Obstructive sleep apnoea3 trials
- Atopic dermatitis (eczema)2 trials
- Alopecia areata1 trial
- Chronic spontaneous urticaria1 trial
- Osteoarthritis1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 319 trials
- Phase 28 trials
- Phase 42 trials
- Status
- Completed13 trials
- Active, not recruiting7 trials
- Recruiting6 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company18 trials
- Pfizer7 trials
- Apnimed1 trial
- Novartis Pharmaceuticals1 trial
- Regeneron Pharmaceuticals1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Enrolling by invitation
Recruiting
Active, not recruiting
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes3 recruiting
- Alopecia areata1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Obstructive sleep apnoea1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older
Completed
Completed
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026